drugset / Trial / NCT00004288
Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis
Phase 2
Completed
4 enrolled
National Center for Research Resources (NCRR)
University of Rochester · collab
Treatment
Summary
OBJECTIVES: I. Assess the safety and efficacy of olsalazine, a dimer of 5-aminosalicylic acid, in men with ankylosing spondylitis unresponsive to nonsteroidal anti-inflammatory drugs and physiotherapy.
Timeline
- Start
- 1996-05
- Primary completion
- —
- Completion
- 1999-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | olsalazine | Small molecule | — | — |